Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-06 4:06 pm Sale |
2024-12-13 | 13D | INNOVEREN SCIENTIFIC, INC. IVRN |
FWHC Holdings, LLC | 0 0.000% |
-697,273 (Position Closed) |
Filing History |
| 2024-02-06 4:00 pm Purchase |
2024-01-16 | 13D | INNOVEREN SCIENTIFIC, INC. IVRN |
FWHC Holdings, LLC | 697,273 34.380% |
697,273 (New Position) |
Filing History |
| 2022-02-25 4:05 pm Purchase |
2022-02-23 | 13D | H-CYTE, Inc. HCYT |
FWHC Holdings, LLC | 697,263 67.740% |
42,302 (+6.46%) |
Filing History |
| 2021-03-11 06:04 am Sale |
2020-09-24 | 13D | H-CYTE, Inc. HCYT |
FWHC Holdings, LLC | 654,961 68.700% |
-18,560 (-2.76%) |
Filing History |
| 2020-09-30 8:09 pm Purchase |
2020-09-24 | 13D | H-CYTE, Inc. HCYT |
FWHC Holdings, LLC | 673,521 69.410% |
24,255 (+3.74%) |
Filing History |
| 2020-07-10 4:13 pm Purchase |
2020-07-06 | 13D | H-CYTE, Inc. HCYT |
FWHC Holdings, LLC | 649,265 69.680% |
619,926 (+2112.94%) |
Filing History |
| 2020-05-20 4:40 pm Unchanged |
2020-04-17 | 13D | H-CYTE, Inc. HCYT |
FWHC Holdings, LLC | 29,340 22.700% |
0 (Unchanged) |
Filing History |